{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 294,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Compilation_Completed"
      ]
     },
     "execution_count": 294,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Important improvements:\n",
    "#    Improve trial success statistical basis\n",
    "#    Replace htxthresh with some sort of probabalistic sampling\n",
    "#    Base p23 n on p1-based power calculation (https://clincalc.com/stats/samplesize.aspx)\n",
    "#    At present, a pt can be treated with many drugs, including any number of drugs for the very same varient!\n",
    "#       This leads to over-the-top improvments, although it's not entirely obvious that this isn't \n",
    "#       a perfectly plausible strategy (cf. the 9-component GBM treatment), esp. before particular \n",
    "#       precision treatments haven't been approved. There are several things we're ignoring, specifically\n",
    "#       combined toxicity and drug interactions.\n",
    "#  Minor issues: \n",
    "#    There's a bug where because of the order of ops, the pts can end up with health << 0 just before death\n",
    "#    Allow \"cures\" (at present you only accrue variants, never lose them!) Maybe when healh == 1.0, clear varvac?\n",
    "#    There's some sort of bug where the trial is transitioned/closed multiple times. \n",
    "#  Possible Improvements:\n",
    "#    Treatments should have a bimodal structure, like variants\n",
    "#    Model decision making agents -- hypers go with d.m. agents\n",
    "#    Maybe txs should stop having an effect; possibly bcs the disease mutates away from the target variant\n",
    "#       to a new biomarker configuration. At present this makes no difference bcs we are assuming that we \n",
    "#       test on every cycle and treat to the results of the test (i.e., we \"chase\" the biomarkers). \n",
    "#       But more correctly we would treat with the same drug until it stops working.\n",
    "\n",
    "using Random\n",
    "using Distributions\n",
    "using Printf\n",
    "#using CPUTime\n",
    "using PyPlot; const plt = PyPlot\n",
    "\n",
    "global gloglevel = 0\n",
    "function log!(msg,lvl=0) \n",
    "    lvl >= gloglevel ? print(msg) : false\n",
    "end\n",
    "\n",
    "##########################################################################################\n",
    "# Globals and Hyperparmaters:\n",
    "##########################################################################################\n",
    "\n",
    "# Values declared as hypers are stored in the ghyps dictionary. This makes it convenient to\n",
    "# save them with run results, but makes access very slow, so use lets to pull them into local around\n",
    "# inner loops. Each entry in the dict is a pair: [current_value, default_value]. In initialization \n",
    "# we call sethyps() to set the current values to either defaiults, or to user-given values.\n",
    "\n",
    "# ******************************************************************************\n",
    "# *** WARNING: Computed hyperparams need to be computed and set in sethyps() ***\n",
    "# *** Any settings here of computed hyper paremeters are placeholders to     ***\n",
    "# *** show the sort of thing that these hyps are.                            ***\n",
    "# ******************************************************************************\n",
    "\n",
    "global ghyps = Dict()\n",
    "\n",
    "macro hyp(variable, value); ghyps[:($variable)] = [eval(:($value)),eval(:($value))]; end\n",
    "macro hyp(variable); :(ghyps[($variable)][1]); end # You have to use :symbols to make this work\n",
    "\n",
    "showhyps() = for (hyp, cd) in ghyps; @printf(\"%s=%s (default=%s)\\n\", hyp, cd[1], cd[2]) ; end\n",
    "\n",
    "# Simplified Beta Hyper Parameters [alpha,beta]\n",
    "@hyp hsbhps Dict(:farleftpeak => [1.5,20], :leftpeak => [3,11], :centered => [10,10], :rightpeak => [11,3])\n",
    "\n",
    "# Get a mean and deviation (usually for normal sampling) centered at the keyed beta, and with the keyed deviation\n",
    "BBMD(Mkey,Dkey) = rand(Beta(@hyp(:hsbhps)[Mkey][1],@hyp(:hsbhps)[Dkey][2])) # BetaBasedMandD\n",
    "\n",
    "##########################################################################################\n",
    "# General Hypers\n",
    "##########################################################################################\n",
    "\n",
    "@hyp npts 30\n",
    "@hyp nvs 10 # n variants describing a patient\n",
    "@hyp nyears 50\n",
    "\n",
    "# Turning this off will circumvent the trial process and go straight to expanded access.\n",
    "@hyp trialsp true\n",
    "\n",
    "##########################################################################################\n",
    "# Treatment-Related Hypers\n",
    "##########################################################################################\n",
    "\n",
    "# Only treat when you get below this level (FFF This should have measurement error!)\n",
    "@hyp htxthresh 0.7\n",
    "\n",
    "# Hypers for positive and negative treatment effect sizes:\n",
    "@hyp espm 0.5\n",
    "@hyp espd 0.1\n",
    "@hyp esnm -0.1\n",
    "@hyp esnd  0.1\n",
    "\n",
    "##########################################################################################\n",
    "# Incidnence and Effect Size of Variants\n",
    "##########################################################################################\n",
    "\n",
    "# Variant occurrance dist (when sampled N>0.5)\n",
    "# ??? Is this too meta? Could just take means from hyper consts rather than sampling them from betas.\n",
    "@hyp hvopds [Normal(BBMD(:farleftpeak,:centered),BBMD(:leftpeak,:centered)) for i in 1:@hyp(:nvs)]\n",
    "\n",
    "@hyp vmm1m 0.05\n",
    "@hyp vmm1d 0.01\n",
    "@hyp vmm2m 0.20\n",
    "@hyp vmm2d 0.10\n",
    "\n",
    "# Because these have to add to 1.0, we compute vmm2w in sethyps(), that way you only have to change vmm1w\n",
    "# to change the mixture. We only need vmm2w here to set the default for vesds\n",
    "@hyp vmm1w 0.95 \n",
    "@hyp vmm2w 0.05 \n",
    "\n",
    "@hyp vmm_effects_dev 0.1 # Deviation for N effect sizes centered on mixture model samples (FFF??? Sample this too?)\n",
    "\n",
    "# Variant effect size (ves) is sampled from a bimodal mixture. NOTE: The effect size here is a \"hit\", that is,\n",
    "# the values here are the NEGATIVE effect of a variant. The bimodality is trying to model most variants having a small\n",
    "# negative effect, and rare variants having a large negative effect.\n",
    "\n",
    "@hyp vmm MixtureModel(Normal[Normal(0.05, 0.01),Normal(0.2, 0.1)],[0.95,0.05]) # Recomputed in init using vmm... hypers\n",
    "@hyp vesds [Normal(rand(@hyp(:vmm)),@hyp(:vmm_effects_dev)) for i in 1:@hyp(:nvs)] # Recomputed in init\n",
    "\n",
    "function printvesds()\n",
    "    log!(\"Variant effect size distributions:\\n\")\n",
    "    for vesd in @hyp(:vesds)\n",
    "        log!(@sprintf(\"%s\\n\",vesd))\n",
    "    end\n",
    "end\n",
    "\n",
    "##########################################################################################\n",
    "# Structs, Global stores, Creators, and Printers\n",
    "##########################################################################################\n",
    "\n",
    "# Pateints are described by binary variant vectors, beginning at [0,...,0] and collecting variants at\n",
    "# the rate given by the variant occurrance probability (vop, per year==cycle). Each variant\n",
    "# also has an effect size (ves), which actually the mean and sd of the gaussian effect size, again, per year. \n",
    "# So, as patients develop variants over time, their health, which begins at 1.0, starts declining in accord\n",
    "# with collected variants. The trial could concienvably be a multie-tx field, but at the moment off-trial \n",
    "# treatments are one-shot and dependent on immediate variant tests, so we don't need to record txs other \n",
    "# than trials. The trial will be false if there's no trial.\n",
    "\n",
    "mutable struct pt; id; health; varvec; history; trial; trial_cycles end\n",
    "global gpts = []\n",
    "ptfmt(pt) = @sprintf(\"{Pt#%2d=%.2f%s{%s}}\",pt.id,pt.health,pt.varvec,ctfmt(pt.trial))\n",
    "mean_survival(pts)=mean(map(pt->((last(pt.history)!=0.0) ? @hyp(:nyears) : (findall(h->h==0.0,pt.history)[1])),pts))\n",
    "pts_with_variant(vn;pts=gpts) = filter(pt->pt.varvec[vn]==1,pts)\n",
    " \n",
    "# A treatment (tx) is just the target variant (by index), an set of effect size distributions (normals), \n",
    "# and an approval status, which is either true, for an approved tx, false for a failed on, or \n",
    "# a clinical trial structure. We create a new targted tx is based on when the number of patients \n",
    "# to die with a particular variant reaches > some % of the population.\n",
    "# The status will either be a trial, or true if it's approved\n",
    "# Effect model (em): [[variant number, effect distrubution]...]\n",
    "mutable struct tx; id; em; status; end\n",
    "global gtxs = []\n",
    "emfmt(em) = string(map(m->@sprintf(\"[%s,N%s]\",m[1],params(m[2])),em))\n",
    "txfmt(tx) = @sprintf(\"<Tx#%2d(%s):%s>\",tx.id,ctshortfmt(tx.status),emfmt(tx.em))\n",
    "# Live Tx Indexes for Variant gives you the indeces of the status=non-false teatments for a given variant.\n",
    "ltxixs4vn(vn) = findall(tx->tx.status!=false&&vn==tx.em[1][1],gtxs)\n",
    "\n",
    "# Clinical trials go trough 2 phases: 1 and 2/3 (23). The first phase seeks to power the second phase. When a new \n",
    "# drug is invented, it goes into a phase 1 trials, and can NOT be used except in the trial. Once it \n",
    "# passes phase 1 (if it does), it goes into a specifically-powered phase 23 trial. At THAT point, anyone\n",
    "# can use the drug. Patients who are enrolled in either a phase 1 or phase 2 trial only get the trial\n",
    "# treatment, whereas patients who are NOT in a trial can get any drug that is in phase 2 or beyond. \n",
    "# So an advantage of going into a phase 1 trials is that you get drug before anyone else. The disadvantage\n",
    "# is that you're stuck with that one drug. One question is, why would anyone who could get the drug anyway,\n",
    "# bother going into a phase 2/3 trial? The answer is that they wouldn't, but that's not the world we live in.\n",
    "# So there is another factor, which is that any patient who CAN go into a trial MUST go into a trial (under the\n",
    "# :strict policy). In :strict there is a health cutoff for the trial, which is based on the phase 1 analysis.\n",
    "# Any patient with the target mutation who passes the health cutoff MUST (under :strict) go into the 23 trial.\n",
    "# The :strict policy is actually more like the real world, and it's probably the comparison case. The other\n",
    "# policy (:open), any can get any drug that has passes phase 1, and so there's no reason that anyone would \n",
    "# go into a phase 23 trial, when they can just get tested all the time, and get whatever drug they want, and\n",
    "# any number of them, and change all the time. In fact, :open is to obviously better than :strict, and so not-\n",
    "# the-way-the-world-really-is, that I haven't even bother to implement :open!\n",
    "\n",
    "@hyp phase1_ptsneeded 3 # This looks like it shouldn't be a constant, but in practice, it actually is!\n",
    "@hyp phase1_duration_per_patient 3 # FFF ??? Maybe go to dose escalation, or patient response\n",
    "@hyp phase23_ptsneeded 3 # FFF Compute from Phase 1 results, see: https://clincalc.com/stats/samplesize.aspx\n",
    "@hyp phase23_duration_per_patient 3 # FFF Ditto should be computed based on phase 1, although less critical than n\n",
    "mutable struct ct; id; txs; pts; phase; ptsneeded; duration_per_patient; end\n",
    "global gcts = []\n",
    "ctfmt(ct) = @sprintf(\"[CT%2dph%d,n=%s]\",ct.id,ct.phase,length(ct.pts))\n",
    "ctfmt(status::Bool) = status\n",
    "ctshortfmt(status::Bool) = status\n",
    "ctshortfmt(ct) = @sprintf(\"[CT%2dp%d]\",ct.id,ct.phase)\n",
    "\n",
    "# Once phase 1 trials are completed, they get converted to phase23 and added to the phase23 list.\n",
    "global phase23_trials = []\n",
    "global completed_trials = []\n",
    "global failed_trials = []\n",
    "\n",
    "# Compute the effectiveness of a treatment on a trial, i.e., the ratio of mean survival on the trial vs. off\n",
    "# The \"off\" pts are those with the target vatiant, but were NOT on the trial. ??? How are we treating right censoring ???\n",
    "trial_result(trial)=let offpts = setdiff(pts_with_variant(trial.txs[1].em[1][1]),trial.pts); (trial.pts == [] || offpts == []) ? :uncomputable : mean_survival(trial.pts)/mean_survival(offpts); end\n",
    "\n",
    "##########################################################################################\n",
    "# Variants (biomarkers)\n",
    "##########################################################################################\n",
    "\n",
    "# Variants are accrued randomly throughout life. \n",
    "\n",
    "# Variant occurs? predicate (i.e., > 0.5) => true/false\n",
    "vop(vn) = (rand(@hyp(:hvopds)[vn]) > 0.5)\n",
    "\n",
    "# Maybe gain a variant (nvs just passed in for efficiency so we don't have to @hyp it)\n",
    "gainvars(varvec,nvs) = [((vop(vn) > 0.5) ? 1 : varvec[vn]) for vn in 1:nvs]\n",
    "\n",
    "# Patient health hit is the amount to reduce the pt's health based on the sum of samples\n",
    "# from all of the accrued variants.\n",
    "function varhealthhit(varvec)\n",
    "    let vesds = @hyp(:vesds)\n",
    "        reduce(+,[varvec[vn]*rand(vesds[vn]) for vn in 1:@hyp(:nvs)])\n",
    "    end\n",
    "end\n",
    "\n",
    "##########################################################################################\n",
    "# Treating and creating new treatments\n",
    "##########################################################################################\n",
    "\n",
    "# The parameters that create new treatments and trials interact complexly:\n",
    "# When the number of patients in a given diagnosis (i.e., a given vn) exceeds txinventiondeathfraction*total population,\n",
    "# there's the possibility of creating a new treatment. Once that level is passed, then a normal draw has to come above\n",
    "# hnewtxthresh in order for the treatment to actually be created. (FFF These could be rolled together.)\n",
    "# Every new treatment gets a new phase 1 trial. txpervnlimit is a hard limit on the number of treatments either \n",
    "# appraoved, or in trials (that is, whose status is not false) for a given diagnosis (vn) (FFF Make this probabalistic.)\n",
    "\n",
    "@hyp txinventiondeathfraction 0.1\n",
    "@hyp hnewtxthresh 0.8\n",
    "@hyp hkilledthresh 999999.999999 # Gets init'ed in init() [Needs to be same type to avoid conv errs]\n",
    "@hyp txpervnlimit 1\n",
    "\n",
    "# Each time a new treatment is created, it is intially created in the context of a clinical trial,\n",
    "# and as long as there is a trial for that treatment available, that's the preferred way to be treated.\n",
    "# In a phase 1 trials, it's the ONLY way you can get treated, but once the trial is in phase 2/3 (23)\n",
    "# anyone who is not in the trial's target model (meaning doesn't have the excluded variants), can get\n",
    "# the treatment, but patients in the trial MUST stay on the trial regimen, whereas others can get the tx\n",
    "# but aren't required to follow protocol if they end up not doing so well on the drug.\n",
    "\n",
    "function mcantxs() # maybe create a new treatment\n",
    "    # For each of the places where the counts of pts killed by particular variants > kill threshold\n",
    "    # decide whether to create a tx, and create it. (Note that there can be more than one tx/variant!)\n",
    "    let hkilledthresh = @hyp(:hkilledthresh), hnewtxthresh = @hyp(:hnewtxthresh), txpervnlimit = @hyp(:txpervnlimit)\n",
    "        killedpts = map(pt->pt.varvec,filter(pt->pt.health==0,gpts))\n",
    "        killedpts != [] ? killedpts = reduce(+,killedpts) : []\n",
    "        log!(@sprintf(\"Patient kill per variant counts: %s (hkilledthresh=%s,hnewtxthresh=%s)\\n\",killedpts, hkilledthresh,hnewtxthresh))\n",
    "        for vn in (killedpts != [] ? findall(x->x>hkilledthresh,killedpts) : [])\n",
    "            # Has to be above the newtx threshold, and can't exceed the number of txs for this var already created\n",
    "            if rand(Normal())>hnewtxthresh && length(ltxixs4vn(vn))<=txpervnlimit\n",
    "                newtx(vn)\n",
    "            end\n",
    "        end\n",
    "    end\n",
    "end\n",
    "\n",
    "# Although each new tx is targeted to a particular variant, we also create side-effect\n",
    "# variant effects with a certain (small) probability. These are generally slightly negative,\n",
    "# whereas \n",
    "\n",
    "function newtx(vn)  # FFF Rationalize the effect size, and add a clinical trial in the status\n",
    "    # First is the main effect (generally +) and one side effect (-centered) FFF Makes these more flexible\n",
    "    # (Also, the main effect and side effect could cancel if they are the same vn -- prob disallow this! FFF UUU)\n",
    "    # Under one FFF theory, there should be a small side effect for EVERY vn -- too complex, maybe some day)\n",
    "    # A new tx gets a phase 1 trial for just this treatment. FFF trials can be started for multiple\n",
    "    # treatments through a different channel.\n",
    "    ntx=tx(1+length(gtxs),[[vn,Normal(@hyp(:espm),@hyp(:espd))],[rand(1:@hyp(:nvs)),Normal(@hyp(:esnm),@hyp(:esnd))]],\n",
    "        true) # Start out approved, and if you're going to run trials, this will get replaced with a phase 1 trial\n",
    "    if @hyp(:trialsp)\n",
    "        nct = ct(1+length(gcts),[ntx],[],1,@hyp(:phase1_ptsneeded),@hyp(:phase1_duration_per_patient))\n",
    "        ntx.status=nct\n",
    "        push!(gcts,nct)\n",
    "    end\n",
    "    push!(gtxs,ntx)\n",
    "    log!(@sprintf(\"Creating new tx: %s\\n\",txfmt(ntx)))\n",
    "end\n",
    "\n",
    "# When you treat a patient, you treat every variant for which he has a positive test\n",
    "# (tests are assumed to be correct! FFF: Probabalize tests!) If there are several possible\n",
    "# approved treatments for a a given variant, you choose one uniformly at random.\n",
    "\n",
    "function treat(pt)\n",
    "    # If the patient is on a trial, the treatment is determined by the trial, \n",
    "    # otherwise, you can treat per variants\n",
    "    ct = pt.trial\n",
    "    if ct == false\n",
    "        find_trial_or_freetreat(pt)\n",
    "    else\n",
    "        # Treat with the trail treatment, and then update the trial stats\n",
    "        log!(@sprintf(\"Treating pt#%s on trial %s\\n\",pt.id,ct.id))\n",
    "        treatwith(pt,ct.txs[1])\n",
    "        # If the pt has been on the trial the required number of cycles, take them off\n",
    "        if ct.duration_per_patient == pt.trial_cycles\n",
    "            log!(@sprintf(\"Taking pt#%s off trial %s\\n\",pt.id,ct.id))\n",
    "            # Nb. Taking a patient off a trial removes the trial from the patient record, but does not \n",
    "            # remove the patient from the TRIAL's record. We always remember which patients we treated on the trial\n",
    "            pt.trial = false\n",
    "            # Consider closing this trial if this is the last patient, and it's not already closed\n",
    "            # Patients can still be on the trial even though it's technically closed.\n",
    "            # No new ones can be recruited, but ones already on can be recruited.\n",
    "            if (length(ct.pts)==ct.ptsneeded)\n",
    "                # If the trial failed, shut down the treatment\n",
    "                let result = trial_result(ct)\n",
    "                    #println(string(\"***************\",result))\n",
    "                    if  (result == :uncomputable || result < 1.0) # ??? uncomputeable trials are assumed to have failed\n",
    "                        log!(@sprintf(\"Trial %s FAILED! Killing TX#%s!\\n\",ct.id,ct.txs[1].id))\n",
    "                        ct.txs[1].status = false\n",
    "                        push!(failed_trials,ct)\n",
    "                    else\n",
    "                        # Close the trial successfully: convert p1 to p23, approve drugs on p23 success\n",
    "                        if ct.phase == 1\n",
    "                            log!(@sprintf(\"Converting trial %s from phase 1 to phase 23\\n\",ct.id))\n",
    "                            push!(phase23_trials,ct)\n",
    "                            ct.phase = 23\n",
    "                            ct.ptsneeded = @hyp(:phase23_ptsneeded)\n",
    "                            # FFF !!! Compute from phase 1 variance: https://clincalc.com/stats/samplesize.aspx\n",
    "                            ct.duration_per_patient == @hyp(:phase23_duration_per_patient)\n",
    "                        else\n",
    "                            log!(@sprintf(\"Trial %s has been completed, approving %s!\\n\",ct.id, ct.txs[1].id))\n",
    "                            push!(completed_trials,ct)\n",
    "                            ct.txs[1].status = true # Mark this treatment as approved!\n",
    "                        end\n",
    "                    end\n",
    "                end\n",
    "            end\n",
    "        else\n",
    "            pt.trial_cycles = pt.trial_cycles + 1\n",
    "        end\n",
    "    end\n",
    "end\n",
    "\n",
    "       \n",
    "function find_trial_or_freetreat(pt)\n",
    "    # The number of patients needed for a trial is used to decide whether a trial is available\n",
    "    # When phase 1 is done, the ptsneeeded will be reset to the appropriate number for p23, and will\n",
    "    # again count up. Once the p23 trial is completed, the ptsneeded will be full up, and won't get\n",
    "    # reset, so the trial will never be selected again.\n",
    "    goodtrials = filter(ct->(applicabletxp(ct.txs[1],pt.varvec)&&(length(ct.pts)<ct.ptsneeded)),gcts) \n",
    "    if goodtrials != []\n",
    "        ct = rand(goodtrials)\n",
    "        pt.trial = ct\n",
    "        pt.trial_cycles = 1\n",
    "        ct.pts=cat(ct.pts,pt,dims=1)\n",
    "        log!(@sprintf(\"Enrolled pt%s in trial %s\\n\",pt.id,ct.id))\n",
    "        treat(pt)\n",
    "    else\n",
    "        log!(@sprintf(\"Free Treating pt#%s\\n\",pt.id))\n",
    "        freetreat(pt)\n",
    "    end\n",
    "end\n",
    "        \n",
    "function applicabletxp(tx,varvec)\n",
    "    # The first elt of the vn array is the target\n",
    "    1==varvec[(map(vn_ves->vn_ves[1],tx.em))[1]]\n",
    "end\n",
    "\n",
    "# If we find a trial that this patient can go on, we do that, otherwise, we treat all the variants they have\n",
    "# The treatment either has to have no attached trials, or anh attached trial must be in phase23. The reason we\n",
    "# might get here even though there are trials for this vn, is that the available trials might be full up.\n",
    "\n",
    "function freetreat(pt)\n",
    "    for vn in findall(v->v==1,pt.varvec)\n",
    "        # Find all possible treatments for this variant:\n",
    "        # And then keep only those that aren't in a trial, or are in phase 23\n",
    "        txs = filter(tx->(tx.status!=false)&&((tx.status==true)||(tx.status.phase==23)),filter(tx->[]!=findall(vn_ves->vn_ves[1]==vn,tx.em),gtxs))\n",
    "        txs != [] ? treatwith(pt,txs[rand(1:end)]) : log!(@sprintf(\"No available treatments!\\n\"))\n",
    "    end\n",
    "end\n",
    "\n",
    "# Treating a patient entails applying an effect size (es) sample from each of the applicable \n",
    "# effect models in the tx. Each em is a pair of a variant number and an effect distribution for that\n",
    "# variant. Even though the variants are chosen to target one particular vn, all the vns that this pt\n",
    "# has will be applied! This models side effects. \n",
    "\n",
    "function treatwith(pt,tx)\n",
    "    log!(@sprintf(\"Treating pt#%s (%.2f) with %s\\n\",pt.id,pt.health,txfmt(tx)))\n",
    "    for (vn,ves) in tx.em\n",
    "        pt.varvec[vn]==1 ? pt.health=pt.health+rand(ves) : false # If this is a side effect, the dist will be negatively biased\n",
    "    end\n",
    "end\n",
    "\n",
    "\n",
    "##########################################################################################\n",
    "# Drivers\n",
    "##########################################################################################\n",
    "\n",
    "function init(loglevel,overrides)\n",
    "    # Clear collectors\n",
    "    global gloglevel=loglevel\n",
    "    global gpts = [pt(p, 1.0, [0 for i in 1:@hyp(:nvs)], [1.0], false, nothing) for p in 1:@hyp(:npts)] # not on any trials to begin with\n",
    "    global gtxs = []\n",
    "    global gcts = []\n",
    "    global phase23_trials = []\n",
    "    global failed_trials = []\n",
    "    global completed_trials = []\n",
    "    sethyps(overrides)\n",
    "end\n",
    "\n",
    "function sethyps(overrides) # overrides is, e.g.: [:foo, 5.2], which will override the default\n",
    "    for (hyp, cd) in ghyps; cd[1]=cd[2]; end # First set everything to default\n",
    "    for (hyp, newval) in overrides; ghyps[hyp][1]=newval; end # Now override anything requested\n",
    "    # *********************************************************************************************\n",
    "    # Now we have to compute computed hypers -- WWW Note that you can't override computed hypers \n",
    "    # bcs they get recomputed here! (Prob. should test for this and barf!)\n",
    "    ghyps[:hkilledthresh][1]=@hyp(:npts)*@hyp(:txinventiondeathfraction)\n",
    "    # Recompute variant effect bimodal mixture\n",
    "    ghyps[:vmm2w][1]=1.0-@hyp(:vmm1w)\n",
    "    ghyps[:vmm][1]=MixtureModel(Normal[Normal(@hyp(:vmm1m), @hyp(:vmm1d)),Normal(@hyp(:vmm2m),@hyp(:vmm2d))],\n",
    "                                [@hyp(:vmm1w),@hyp(:vmm2w)])\n",
    "    @hyp vesds [Normal(rand(@hyp(:vmm)),@hyp(:vmm_effects_dev)) for i in 1:@hyp(:nvs)] # ??? Should this be a setf?\n",
    "    # *********************************************************************************************\n",
    "    # For efficiency this replicates the printlevel test to block the whole loop (much ado ...)\n",
    "    gloglevel <= 5 ? showhyps() : []\n",
    "end\n",
    "\n",
    "seevmm()=plt.hist(rand(@hyp(:vmm),1000),100)\n",
    "\n",
    "# Test shows lots of logging whereas run shows none, and averages the average mortalities over all runs.\n",
    "# You can override any hyperparameter on either with overrides=[[:hyp,newval],...]\n",
    "# ** Note that overrides, if you use them, have to be a list of lists, as: overrides=[[:foo,10],[:bar,20]]\n",
    "\n",
    "function test(;overrides=[],loglevel=0) # Watch as variants accrue and health declines\n",
    "    init(loglevel,overrides)\n",
    "    log!(printvesds())\n",
    "    let nyears = @hyp(:nyears), htxthresh = @hyp(:htxthresh), nvs = @hyp(:nvs)\n",
    "        for year in 1:nyears\n",
    "            log!(@sprintf(\"\\n-------- %s --------\\n\",year))\n",
    "            for pt in gpts\n",
    "                # There's a sort of which-comes-first problem here about changing health level, then zero'ing it out\n",
    "                # if it's under 0, and then treating or not. Probably this logic could be simplified a bit FFF ???\n",
    "                pt.varvec=gainvars(pt.varvec,nvs)\n",
    "                (pt.health > 0) ? (pt.health=pt.health-varhealthhit(pt.varvec)) : false # Not sure why this syntax requires an else (:) ???\n",
    "                # (FFF Probably do this with tanh instead of these hard limits?)\n",
    "                (pt.health <= 0) ? (pt.health = 0) : (pt.health < htxthresh ? treat(pt) : false)\n",
    "                (pt.health >= 1.0) ? (pt.health = 1.0) : false \n",
    "                push!(pt.history,pt.health)\n",
    "            end\n",
    "            mcantxs()\n",
    "        end\n",
    "        if loglevel == 0\n",
    "            plt.plot([[[pt.history for pt in gpts][i][j] for i in 1:ghyps[:npts][1]] for j in 1:nyears]) # UUU Array rotation\n",
    "            #plt.text(nyears-20,-0.2,\"maybe add a label?\")\n",
    "            plt.ylabel(\"Health\")\n",
    "            plt.xlabel(\"Years from Diagnosis\")\n",
    "                       println(\"\\n\\nTrial results:\\n\")\n",
    "            map(x->println(x),[trial_result(gcts[i]) for i in 1:length(gcts)])\n",
    "            for (obs,fmtfn) in ((gpts, ptfmt),(gtxs,txfmt),(gcts,ctfmt)); map(ob->@printf(\"%s\\n\",fmtfn(ob)),obs); end\n",
    "            @printf(\"\\nTotal trials: %s, Completed trials: %s, Failed trials: %s\\n\",\n",
    "                    length(gcts), length(completed_trials), length(failed_trials))\n",
    "            println(\"\\nHyper paramters:\\n\"); show(ghyps)\n",
    "        end\n",
    "        return Dict(:mean_survival=>mean_survival(gpts),\n",
    "                    :n_all_trials=>length(gcts),\n",
    "                    :n_completed_trials=>length(completed_trials), \n",
    "                    :n_failed_trials=>length(failed_trials),\n",
    "                    :n_phase23_trials=>length(phase23_trials)\n",
    "                    )\n",
    "    end\n",
    "end\n",
    "\n",
    "run(;n=10,overrides=[])=[test(loglevel=99,overrides=overrides) for i in 1:n] \n",
    "\n",
    "# Scan Run (srun) scans a single hyp value. frun can do more complex scanning.\n",
    "# Examples:\n",
    "#srun(:txinventiondeathfraction,0.0,1.0,0.1,n=20)\n",
    "#srun(:htxthresh,0.0,1.0,0.1,n=20)\n",
    "#srun(:htxthresh,0.0,1.0,0.1,n=20,otheroverrides=[[:trialsp,false]])\n",
    "\n",
    "function run(overkey::Symbol,from::Real,to::Real,step::Real;result_key=:mean_survival,n=10,otheroverrides=[])\n",
    "    local all_results = []\n",
    "    let overrider = [[overkey,999.999]]\n",
    "        for val in from:step:to\n",
    "            overrider[1][2]=val\n",
    "            # Each run will give you a single number per run, we collect them and then do the mean and std of these\n",
    "            results = map(r->r[result_key],run(n=n,overrides=vcat(overrider,otheroverrides)))\n",
    "            #@printf(\"@%s=%s\\n\",overkey,val)\n",
    "            push!(all_results,[val,results])\n",
    "        end\n",
    "    end\n",
    "    let x=[x[1] for x in all_results], y=[mean(x[2]) for x in all_results]\n",
    "        plt.scatter(x,y) \n",
    "        plt.plot(x,y) \n",
    "        plt.errorbar(x, y, yerr=[(std(x[2])/sqrt(n)) for x in all_results])\n",
    "        plt.ylabel(result_key)\n",
    "        plt.xlabel(string(overkey))\n",
    "    end\n",
    "    :Done\n",
    "end\n",
    "\n",
    "\n",
    "\"\"\"\n",
    "# !!! Needs to get unified with the the run that scans single values !!!\n",
    "\n",
    "# This takes a generator structure and a terminator function. The generator\n",
    "# function looks like: [[:hyper,initval,#'nextfn(preval)],...] which are used\n",
    "# to set the initial value of the indicated hypers, and then increment it each\n",
    "# time around, and this continues until the terminator fn comes up true.\n",
    "# The first [1] entry in the overrider array is assumed to be the plotkey.\n",
    "# Termfn gets passed the overrider array. If can often just check the [1][2] value of that array.\n",
    "# Example: #frun([[:htxthresh,0.0,x->x+0.1]],array->array[1][2]>=1.0)\n",
    "\n",
    "function run(genstruct::Array{Any},termfn::Function;n=10,otheroverrides=[])\n",
    "    local results = []\n",
    "    let overrider = [[key,initval] for (key,initval,nextvalfn) in genstruct] \n",
    "        while !termfn(overrider)\n",
    "            result = run(n=n,overrides=vcat(overrider,otheroverrides))\n",
    "            @printf(\"@%s=%s:%s\\n\",overrider[1][1],overrider[1][2],result)\n",
    "            push!(results,[overrider[1][2],result])\n",
    "            for i in length(genstruct); overrider[i][2]=genstruct[i][3](overrider[i][2]); end\n",
    "        end\n",
    "    end\n",
    "    let x=[x[1] for x in results], y=[x[2][1] for x in results]\n",
    "        plt.scatter(x,y) \n",
    "        plt.plot(x,y) \n",
    "        plt.errorbar(x, y, yerr=[(x[2][2]/sqrt(n)) for x in results])\n",
    "        plt.ylabel(\"Mean Survival\")\n",
    "        plt.xlabel(string(genstruct[1][1]))\n",
    "    end\n",
    "    return(results)\n",
    "end\n",
    "\"\"\"\n",
    ":Compilation_Completed\n",
    "#frun([[:htxthresh,0.0,x->x+0.1]],array->array[1][2]>=1.0)\n",
    "#test(overrides=[[:espm,-1.5]])\n",
    "#run(:txinventiondeathfraction,0.0,1.0,0.1,n=20)\n",
    "#run(:htxthresh,0.0,1.0,0.1,n=20)\n",
    "#run(:htxthresh,0.0,1.0,0.1,n=20,otheroverrides=[[:trialsp,false]])\n",
    "#run(:espm,0.5,-0.5,-0.1,n=20,otheroverrides=[[:trialsp,true]])\n",
    "#run(:htxthresh,0.0,1.0,0.1,n=20,otheroverrides=[[:trialsp,false]])\n",
    "#run(:htxthresh,0.0,1.0,0.1,n=20,otheroverrides=[[:trialsp,true]])\n",
    "# Scanning the size of treatment effect primary mode\n",
    "#run(:espm,0.5,-0.5,-0.1,n=20,otheroverrides=[[:trialsp,true]])\n",
    "#run(:espm,0.5,-0.5,-0.1,n=20,otheroverrides=[[:trialsp,false]])\n",
    "#run(:vmm1w,0.5,0.95,0.1,n=20) # Scanning the mixture weights of tx effectiveness -- seems to make no difference! ???\n",
    "# Experiments scanning the size and duration of trials:\n",
    "#run(:phase23_duration_per_patient,3,33,5,n=20)\n",
    "#run(:phase23_ptsneeded,3,33,5,n=20)\n",
    "#run(:phase1_ptsneeded,3,33,2,n=100,result_key=:mean_survival,otheroverrides=[[:espm,-1.0]])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 304,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "Figure(PyObject <Figure size 640x480 with 1 Axes>)"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       ":Done"
      ]
     },
     "execution_count": 304,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "run(:espm,0.3,1.3,0.2,n=200,otheroverrides=[[:trialsp,false],[:espd,0.01]])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 303,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "Figure(PyObject <Figure size 640x480 with 1 Axes>)"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       ":Done"
      ]
     },
     "execution_count": 303,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "run(:espm,0.3,1.3,0.2,n=200,otheroverrides=[[:trialsp,true],[:espd,0.01]])"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Julia 1.5.2",
   "language": "julia",
   "name": "julia-1.5"
  },
  "language_info": {
   "file_extension": ".jl",
   "mimetype": "application/julia",
   "name": "julia",
   "version": "1.5.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
